Human breast cancer: androgen action mediated by estrogen receptor
- PMID: 622569
- DOI: 10.1126/science.622569
Human breast cancer: androgen action mediated by estrogen receptor
Abstract
Growth of the human breast cancer cell line MCF-7 is enhanced by androgens, but only at pharmacological concentrations. Although physiological concentrations of androgens translocate the androgen receptor into the nucleus, no mitogenic effects are observed. By contrast, pharmacological androgens translocate not only the androgen receptor but also the estrogen receptor, and at these high doses significantly increase both DNA and estrogen-dependent protein synthesis. We therefore propose that androgens stimulate MCF-7 cell growth not through the androgen receptor but rather through the estrogen receptor.
Similar articles
-
Onset of androgen action in MCF-7 human breast cancer cells is not accompanied by receptor depletion.J Steroid Biochem. 1985 Jan;22(1):15-20. doi: 10.1016/0022-4731(85)90136-0. J Steroid Biochem. 1985. PMID: 3871880
-
Effects of androgens on proliferation and progesterone receptor levels in T47D human breast cancer cells.Tumour Biol. 1993;14(1):38-45. doi: 10.1159/000217823. Tumour Biol. 1993. PMID: 8493449
-
The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture.Cancer Res. 1976 Dec;36(12):4610-8. Cancer Res. 1976. PMID: 1000506
-
[Dual effects of androgens on mammary gland].Bull Cancer. 2008 May;95(5):495-502. doi: 10.1684/bdc.2008.0631. Bull Cancer. 2008. PMID: 18541513 Review. French.
-
Steroid receptors in breast tumors--current status.Curr Top Exp Endocrinol. 1978;3:93-129. Curr Top Exp Endocrinol. 1978. PMID: 350504 Review. No abstract available.
Cited by
-
Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line.Breast Cancer Res Treat. 1988 Oct;12(2):213-25. doi: 10.1007/BF01805942. Breast Cancer Res Treat. 1988. PMID: 3242650
-
High levels of oestrogen receptor-alpha in tumorigenesis: inhibition of cell growth and angiogenic factors.Cell Prolif. 2001 Aug;34(4):223-31. doi: 10.1046/j.0960-7722.2001.00207.x. Cell Prolif. 2001. PMID: 11529880 Free PMC article.
-
17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production.Mol Endocrinol. 2010 Apr;24(4):832-45. doi: 10.1210/me.2009-0468. Epub 2010 Feb 19. Mol Endocrinol. 2010. PMID: 20172961 Free PMC article.
-
Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?Mol Endocrinol. 2012 Aug;26(8):1252-67. doi: 10.1210/me.2012-1107. Epub 2012 Jun 28. Mol Endocrinol. 2012. PMID: 22745190 Free PMC article. Review.
-
Fluoxymesterone stimulation of tumor marker secretion in patients with breast carcinoma.Breast Cancer Res Treat. 1986;8(3):205-15. doi: 10.1007/BF01807333. Breast Cancer Res Treat. 1986. PMID: 3593986
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources